“Telehealth company that stopped compounding after shortages ended.”

“Healthcare company whose CEO was recently interviewed regarding pill demand.”

“Company mentioned for its work with GLP-1s and longevity.”

“We've earned a good ROE for the past 17 years of north of 15%.”